Penserra Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Penserra Capital Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,330	Closed	-$45K	–	1591
2021 Q3	$45K	Buy	1,330 +10	+0.8%	+$319	﹤0.01%	1081
2021 Q2	$48K	Buy	1,320 +20	+2%	+$774	﹤0.01%	1015
2021 Q1	$58K	Sell	1,300 -5	-0.4%	-$233	﹤0.01%	796
2020 Q4	$74K	Buy	1,305 +823	+171%	+$48.8K	﹤0.01%	628
2020 Q3	$24K	Buy	+482	New	+$23.6K	﹤0.01%	717

Other funds holding DCPH

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Penserra Capital Management's DCPH Position: Q4 2021 in Review

Penserra Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2021, closing a stake of 1,330 shares — an estimated $45K sold.

Penserra Capital Management first reported a position in DCPH in Q3 2020 and held it in 5 quarters. The position peaked at $74K in Q4 2020. 140 funds tracked by Wall St. Rank hold DCPH as of Q4 2021.

Penserra Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Penserra Capital Management sold 1,330 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $45K.
Penserra Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 5 quarters.
Penserra Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $74K in Q4 2020.
140 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.